Neurological Disease History
c. 1395, hagiographic records of Lidwine of Schiedam, Netherlands
Multiple sclerosis is a disease whose history is inseparable from the development of systematic clinical neurology in nineteenth-century Europe. Before the era of careful hospital-based observation and post-mortem examination, the condition's variable and relapsing nature made it nearly impossible to distinguish from other neurological disorders. The story of its identification is a story of meticulous observation gradually imposing order on a baffling clinical puzzle.
Historical Narrative
The earliest candidate for a historical case of multiple sclerosis comes from medieval Europe. Lidwine of Schiedam, a Dutch mystic born in 1380, experienced a series of neurological episodes beginning after a skating accident in her teens — including visual disturbances, limb weakness, and facial pain — that progressed over decades. Her case was documented in religious hagiographies and has been retrospectively analyzed by medical historians who find it consistent with multiple sclerosis, though such retrospective diagnoses are inherently speculative. Another frequently cited case is that of Augustus d'Esté, a grandson of King George III of Britain, who kept a diary from 1822 onwards recording episodes of visual disturbance, limb weakness, bladder problems, and remissions, now considered among the earliest first-person accounts of what was likely multiple sclerosis.
The formal medical recognition of the disease emerged from the French clinical tradition of the nineteenth century. Robert Carswell, a Scottish pathologist, produced detailed anatomical illustrations in 1838 showing unusual discolored patches in the spinal cord and brainstem of a deceased patient, and his French colleague Jean Cruveilhier published similar observations in 1835, noting hardened plaques in the nervous system. Neither man recognized these findings as belonging to a distinct clinical syndrome.
The true systematizer of multiple sclerosis as a disease entity was Jean-Martin Charcot. Working at the Salpêtrière hospital in Paris through the 1860s, Charcot and his colleague Edmé Vulpian carefully correlated clinical observations in living patients with post-mortem neuropathological findings. Charcot delivered his landmark lectures on 'sclérose en plaques' in 1868, providing the first comprehensive clinical and pathological description of the disease as a distinct entity. He identified the characteristic hardened plaques of demyelination in the white matter of the brain and spinal cord and distinguished the condition from Parkinson's disease and other trembling disorders with which it had previously been confused.
In the late nineteenth century, German and Austrian neurologists contributed important refinements. Wilhelm Erb, Carl Westphal, and others expanded the clinical description based on large hospital populations. The early twentieth century saw increasing attention to the episodic, relapsing nature of the disease and its puzzling geographic distribution, with researchers noting that the condition appeared far more common in northern latitudes. Joseph Babinski contributed neurological examination techniques that became important diagnostic tools in the absence of laboratory tests. By mid-century, the development of laboratory science began to reveal the immunological peculiarities of the disease, shifting investigation toward the relationship between the nervous system and the body's immune processes.
Key Historical Figures
Historical narrative only — this page describes how Multiple Sclerosis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.